Home 2022

Yearly Archives: 2022

2022 Watch List

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine...

Editor / Curator -
Mitesco
Research

Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165%...

Editor / Curator -
2021 Watch List

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study...

Editor / Curator -
Marijuana Stock Review

Surna Cultivation Technologies Signs Contract for New Addition to Product Portfolio

Editor / Curator -
Internet News

DCS (DCSX) Announces Strategic Partnership with Streamline Transportation Technologies to Kick-off...

Editor / Curator -
All News

Video: China’s Evergrande. The $300 Billion Unwind has Started. Lehman Bros.,...

Editor / Curator -
All News

Adding Smart for Life (SMFL) $0.85 to the Watch List.

Editor / Curator -
2022 Watch List

Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next...

Editor / Curator -
CEA Industries
All News

Surna Cultivation Technologies Signs $2.1 Million Contract

Editor / Curator -
All News

Adding CEA Industries (CEAD) $2.05 to Watch List.

Editor / Curator -
1...10111213Page 11 of 13

Latest article

Party Time at uniQure (QURE). $48 up 443%

Uncategorized Editor / Curator -
No Bells, no Baskets. But Still not out of the Woods!

We’re Up 360% in Six Weeks. Replimune (REPL).

2026 Biotech 12 Pack Editor / Curator -
That's a Gain of $604 Million, and That Ain't Bad! Six brokerage firms downgraded Replimune (REPL), around the same time we added it to...

GeoVax (GOVX) Conference Call and Transcript.

2026 Biotech 12 Pack Editor / Curator -
Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah. Guess what we'll choose to do? We have no...